We're making updates and relaunching soon. Get notified

Straight answers about GLP-1 medications

Plain-language guides on dosing, side effects, costs, and what to look for in a provider.

Relaunching Soon

  • Relaunching as an independent GLP-1 guide
  • Get notified when we relaunch
  • We only ask for your email
Get Started

One email to confirm. Unsubscribe anytime.

Does Insurance Cover GLP-1 for Weight Loss? 2026 Guide

If you are hoping your insurance will cover GLP-1 medication for weight loss, you are not alone. And the answer, frustratingly, is: it depends on your plan, your diagnosis, your prior treatment history, and whether your provider can get through prior authorization.

For most people, the short version is this: the Medicare Part D benefit generally does not cover it for weight management only, though a temporary CMS program now reaches some Part D enrollees. Private insurance coverage is inconsistent and often requires jumping through multiple hoops. FSA and HSA funds may apply, depending on IRS rules and your plan. And cash-pay programs exist as an alternative to the insurance process altogether.

Here is the full picture.

Transformation Health is an independent guide, not a provider: we do not prescribe, sell medication, or bill insurance. This content is for general education and is not medical advice. Talk with a licensed provider about your situation.

Medicare Part D and GLP-1 medications

Medicare Part D covers prescription drugs, but it generally does not cover GLP-1 medications when prescribed solely for weight management.

This restriction comes from the statute. Federal law lists “agents when used for anorexia, weight loss, or weight gain” among the drugs that may be excluded from coverage, and the Part D definition of a covered drug carries that exclusion over.[1][2]

What Part D may cover: Plans may cover GLP-1 medications for other FDA-approved uses, such as type 2 diabetes, usually with plan rules such as prior authorization. If the same medication is prescribed only for weight management, the Part D benefit generally does not cover it.

The Medicare GLP-1 Bridge: CMS is running a short-term demonstration, the Medicare GLP-1 Bridge, that provides eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026 and December 31, 2027. It operates outside the Part D benefit’s coverage and payment flow, so it does not change the statutory exclusion.[3] As of 2026-10-16, the CMS page lists a flat copay, notes that the Part D deductible does not apply, and says the low-income subsidy does not reduce it. Eligibility criteria and covered products are set by CMS and can change; see our Medicare GLP-1 Bridge guide and check the CMS page or 1-800-MEDICARE before you count on it.

Pending legislation: Bills to let Medicare cover anti-obesity medications have been proposed, but as of 2026-10-16 the exclusion is still in the statute.[1][2] Coverage should not be assumed based on pending legislation.

For a full breakdown of Medicare Part D rules and what they cover, see: Medicare Part D and weight loss medications.

Private insurance: coverage varies widely

Private insurance coverage for GLP-1 weight management medications exists, but it is far from universal. Some, but not all, insurance plans cover medications that treat overweight and obesity.[5] Here is what generally determines whether your plan covers it.

Employer-sponsored plans have the most variability. Large self-insured employers make their own benefit decisions and can choose to include or exclude weight loss medications. Coverage can change from one plan year to the next. Your HR benefits team or plan documents are the only reliable way to find out.

ACA marketplace plans set their own formularies within federal and state rules, and many do not include weight loss medications. Coverage depends on the specific plan you selected, so check that plan’s formulary.

Medicaid varies by state. Federal law lets state Medicaid programs exclude drugs used for weight loss, and CMS says Medicare and Medicaid currently generally do not cover GLP-1s for the weight loss indication.[2][4] Some states do cover them, and state decisions change, so check your state Medicaid program’s preferred drug list or prior authorization criteria, or call your state Medicaid office.

What typically triggers coverage when it applies:

  • An adult BMI of 30 or higher, or 27 or higher with at least one weight-related health problem such as high blood pressure or type 2 diabetes, which mirrors the criteria providers use for weight management medications[5]
  • Documentation that other weight management interventions (diet counseling, behavioral therapy, other medications) have been attempted and were insufficient
  • A diagnosis code from your provider that maps to the covered indication
  • Approval through the plan’s prior authorization process

Each plan sets its own criteria. For a detailed breakdown of which plans are most likely to cover weight loss medications, see: What insurance covers weight loss medication.

Prior authorization: what the process actually involves

Prior authorization (PA) is the process by which your insurance plan requires advance approval before it will cover a specific medication. For GLP-1 weight management prescriptions, plans that cover these medications usually require it.

What your provider needs to submit:

  • Your relevant diagnosis codes. For weight management, this is usually an obesity code from the ICD-10-CM E66 category, often paired with a Z68 code that documents your BMI. If you have qualifying comorbidities, those codes are typically included as well. See: ICD-10 codes for obesity and GLP-1 coverage
  • Documentation of prior treatment. Your plan will typically require evidence that you have attempted other weight management approaches. This might include prior prescriptions, referrals to dietitians, participation in structured weight management programs, or primary care notes.
  • Clinical rationale. Your provider submits a letter explaining why the GLP-1 medication is clinically appropriate for your situation.

How long it takes: PA decisions can take days to weeks depending on the plan. Urgent reviews are usually faster; standard reviews can sit in a queue. Denials can be appealed, which adds more time.

What happens if you are denied: You have the right to appeal. Your provider can submit additional documentation or request a peer-to-peer review (where your provider speaks directly with the plan’s medical reviewer). Appeals succeed in some cases. The process is real work, and not everyone has a provider with the capacity or willingness to pursue it aggressively.

For a step-by-step guide to the prior authorization process, see: GLP-1 prior authorization: how to work through it.

FSA and HSA: what applies and what does not

Flexible Spending Accounts (FSA) and Health Savings Accounts (HSA) are two different tax-advantaged accounts that can be used to pay for qualifying medical expenses. Whether either can pay for a GLP-1 prescription is a tax and plan question.

FSA (Flexible Spending Account): A benefit offered through some employers where you set aside part of your pay before tax. Health FSAs are generally “use-it-or-lose-it” plans, though a plan can allow either a grace period or a limited carryover. You can generally be reimbursed up to the full amount you elected for the year at any time during the coverage period.[7]

HSA (Health Savings Account): Available only to people covered by a high deductible health plan (HDHP) who meet the other eligibility rules. Contributions remain in the account until you use them, and interest or other earnings in the account are tax free.[7]

IRS guidance: IRS Publication 502 (2025) says you can include amounts you pay for prescribed medicines in medical expenses.[6] IRS Publication 969 (2025) says qualified medical expenses for HSAs and health FSAs are generally those that would qualify for the medical expense deduction; for an FSA, they are the expenses specified in the plan.[7] Your plan administrator or a tax professional is the right place to confirm your specific account’s rules, especially if a program’s monthly fee bundles medication with other services. Whether a program accepts HSA or FSA cards is up to that program.

For a detailed breakdown of FSA vs. HSA rules for weight loss medications, see: FSA and HSA for weight loss medications.

Manufacturer savings programs: what they are and who they apply to

For branded GLP-1 medications, the manufacturers offer savings programs designed to reduce the cost for commercially insured patients. These programs are worth knowing about, though they come with significant restrictions.

Who these programs cover: Manufacturer copay savings programs are generally built for patients with commercial (private) insurance who meet the clinical criteria for the medication. Their terms typically exclude people with government insurance such as Medicare or Medicaid.

What they do: They can reduce the patient’s out-of-pocket cost at the pharmacy, sometimes substantially, for people whose plan covers the medication. The manufacturer absorbs the difference. Check the manufacturer’s current terms for the amount and any limits.

What they do not do: They generally do not help patients whose plan does not cover the medication, and their terms typically exclude Medicare and Medicaid enrollees. Some manufacturers offer separate self-pay options for people without coverage; check the manufacturer’s current self-pay page.

These programs are specific to branded medications. They do not apply to compounded versions.

For a full list of available savings programs for weight loss medications in 2026, see: Weight loss medication savings programs.

Program options to review

A significant portion of the people who would benefit from GLP-1 treatment fall outside the coverage scenarios above. They do not have qualifying insurance. They are on Medicare. Their plan excludes weight loss medications. Or they have insurance but cannot get through prior authorization in any reasonable timeframe.

Cash-pay telehealth programs are one alternative. You do not file with insurance. At most telehealth programs, you complete an online intake form, a licensed provider reviews your health history and decides whether a prescription is appropriate, and if it is, the prescription goes to a pharmacy. Many programs that serve cash-pay patients prescribe compounded semaglutide or tirzepatide prepared by a compounding pharmacy.

What to confirm before you choose a program:

  • Which medication and dose the monthly price covers, and whether the price changes as the dose increases
  • Whether provider visits, follow-ups, and lab work are included or billed separately
  • Which pharmacy prepares or fills the medication, and that pharmacy’s state license
  • Shipping, membership, or setup fees
  • Cancellation terms, including whether you are billed in advance
  • Which payment methods the program accepts

“All-inclusive” is a program’s own label, and it means different things at different programs. Prices vary by program and dose, so check each program’s current pricing page and compare the total cost: medication, dose increases, visits, labs, shipping, membership fees, and cancellation terms.

Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products.[8] A licensed provider decides whether a prescription is appropriate.

Transformation Health does not accept payment from providers. How we make money.

What’s in this section

This section covers insurance, Medicare, and savings programs across the supporting pages below:

Medicare Part D and weight loss medications - The statutory weight-loss exclusion, the uses Part D can cover (such as type 2 diabetes, cardiovascular risk reduction, and sleep apnea), and how the Medicare GLP-1 Bridge fits in.

What insurance covers weight loss medication - A plan-type breakdown of which commercial insurance plans are most likely to cover GLP-1 medications and what criteria typically apply.

GLP-1 prior authorization: how to work through it - A step-by-step guide to the prior authorization process, what documentation is needed, and how to appeal a denial.

Insurance denied your GLP-1? Your options - What to do after a denial: reading the reason, appealing, and the cash-pay route if coverage stays no.

Insurance stopped covering your weight loss medication: what now - What to do when your plan drops GLP-1 coverage mid-treatment: why it is happening, how to confirm what changed, and three options to keep going.

Weight loss medication savings programs - A summary of available manufacturer savings programs, who qualifies, and how to access them.

FSA and HSA for weight loss medications - A detailed comparison of FSA and HSA rules, what qualifies as a medical expense, and how to use these accounts with a telehealth program.

ICD-10 codes for obesity and GLP-1 coverage - The diagnosis codes used for obesity and related comorbidities, how they affect prior authorization decisions, and what they mean for coverage.

Coverage by plan and program

Coverage rules differ by insurer, pharmacy benefit manager, and government program. These guides cover the biggest ones, with the criteria and 2026 changes for each:

UnitedHealthcare GLP-1 coverage - Why coverage depends on your employer’s election, the prior authorization criteria, and what to do if your plan excludes it.

Aetna GLP-1 coverage - The 2025 formulary changes, which medications remain covered where the benefit exists, and the exception process.

Cigna GLP-1 coverage - What the 2026 headlines actually meant, the employer buy-up model, and the out-of-pocket cap program.

Blue Cross Blue Shield GLP-1 coverage - Each Blue company sets its own coverage: what several Blue plans say about GLP-1s for weight loss, dated.

Kaiser Permanente GLP-1 coverage - Coverage by Kaiser region and plan, the California base-plan change, and how to check yours.

Humana GLP-1 coverage - Medicare rules, indication-based coverage, and how the Medicare GLP-1 Bridge changes the picture.

CVS Caremark GLP-1 coverage - What the Caremark drug list shows for weight-loss GLP-1s, the 2025 Zepbound removal and its October 2026 return, and why your plan still decides.

Express Scripts GLP-1 coverage - The standard formulary exclusion, the employer buy-up, and the monthly out-of-pocket cap arrangement.

Optum Rx GLP-1 coverage - What the Optum Rx formulary lists for weight-loss GLP-1s, and why your employer or plan still decides coverage.

Ambetter GLP-1 coverage - What Ambetter marketplace drug lists say about weight-loss GLP-1s, and how to check a plan before you enroll.

TRICARE GLP-1 coverage - The real prior authorization criteria for military members, and the TRICARE For Life change.

VA GLP-1 coverage - Non-formulary status, the MOVE! pathway, and which covered indications can apply for veterans.

The Medicare GLP-1 Bridge program - The temporary flat-copay program running July 2026 through December 2027: who qualifies and how it works.

The BALANCE model and state Medicaid - What the CMS BALANCE Model is, what several states’ Medicaid documents say, and how to check your state.

Back to the GLP-1 cost and pricing overview.

Getting started without waiting for insurance

If you have been waiting to resolve the insurance question before moving forward, that wait can stretch on. Prior authorization alone can take weeks, and for many people the coverage answer is ultimately no.

You can look at your options in parallel: keep the insurance request moving, and compare cash-pay programs on their total cost and terms at the same time. Some states require a live video visit before certain prescriptions can be written; a program should tell you if that applies where you live.

We're relaunching soon

We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.

Get Started

Citations

[1] 42 U.S.C. 1395w-102(e)(2)(A) (definition of covered Part D drug; exclusions). https://www.law.cornell.edu/uscode/text/42/1395w-102

[2] 42 U.S.C. 1396r-8(d)(2)(A) (drugs that may be excluded or restricted: “agents when used for anorexia, weight loss, or weight gain”). https://www.law.cornell.edu/uscode/text/42/1396r-8

[3] Centers for Medicare and Medicaid Services. “Medicare GLP-1 Bridge.” Accessed 2026-10-16. https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge

[4] Centers for Medicare and Medicaid Services. “BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model.” Accessed 2026-10-16. https://www.cms.gov/priorities/innovation/innovation-models/balance

[5] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Prescription Medications to Treat Overweight and Obesity.” Accessed 2026-10-16. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity

[6] Internal Revenue Service. “Publication 502 (2025), Medical and Dental Expenses.” https://www.irs.gov/publications/p502

[7] Internal Revenue Service. “Publication 969 (2025), Health Savings Accounts and Other Tax-Favored Health Plans.” https://www.irs.gov/publications/p969

[8] U.S. Food and Drug Administration. “Compounding and the FDA: Questions and Answers.” https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. transformationhealth.com is a website operated by Amerigo Health LLC. Transformation Health is an independent publisher. It does not provide medical care, prescribe, or sell medication, does not bill insurance, and does not give medical advice. A licensed provider decides whether a prescription is appropriate. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products. Coverage rules change; confirm current details with your plan, CMS, or your state Medicaid program. Transformation Health does not accept payment from providers. How we make money.

FAQ

Frequently Asked Questions

Everything you need to know about getting started.

Still have questions?

Contact our support team
Does Medicare cover GLP-1 medications for weight loss?
Generally not through Part D. Federal law lets Part D exclude drugs used for weight loss, so Part D plans generally do not cover GLP-1 medications prescribed for weight management alone. Plans may cover them for other FDA-approved uses, such as type 2 diabetes, usually with rules like prior authorization. Separately, CMS is running a short-term demonstration, the Medicare GLP-1 Bridge, that gives eligible Part D enrollees access to certain GLP-1 drugs from July 1, 2026 through December 31, 2027, outside the Part D benefit (CMS, accessed 2026-10-16). Check the CMS Bridge page or call 1-800-MEDICARE for current eligibility rules.
Does private insurance cover semaglutide or tirzepatide for weight loss?
It varies significantly by plan. Some, but not all, insurance plans cover medications that treat overweight and obesity, according to the National Institute of Diabetes and Digestive and Kidney Diseases. Plans that cover them often require prior authorization, and many use criteria close to the medications' approved uses (for adults, a BMI of 30 or higher, or 27 or higher with a weight-related condition) plus documentation of prior treatment attempts. Check your plan's formulary and prior authorization requirements directly with your insurer.
What is prior authorization and how does it work for GLP-1?
Prior authorization (PA) is a process where your insurance plan requires your provider to submit documentation before it will cover a medication. For GLP-1 medications, PA typically requires diagnosis codes for obesity or a qualifying comorbidity, documentation that other treatments have been attempted, and the prescribing provider's clinical rationale. The process can take days to weeks depending on the plan.
Can I use FSA or HSA funds for GLP-1 weight loss medication?
It depends on your plan and IRS rules, so treat it as a tax question. IRS Publication 502 (2025) lists amounts you pay for prescribed medicines as medical expenses, and IRS Publication 969 (2025) says qualified medical expenses for HSAs and health FSAs are generally those that would qualify for the medical expense deduction (for an FSA, as specified in the plan). Check with your plan administrator or a tax professional before you pay. Whether a program takes HSA or FSA cards is up to that program.
What does GLP-1 medication cost without insurance?
It depends on the product, the dose, and where you fill the prescription. Prices vary by program and dose, so check the manufacturer's current self-pay pricing page for brand-name products and each program's current pricing page for compounded products. Then compare the total cost, not just the headline monthly price, including dose increases, provider visits, lab work, shipping, membership fees, and cancellation terms.

We're relaunching soon

We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.

Get Started

About This Site: Disclosures

Who We Are

transformationhealth.com is a website operated by Amerigo Health LLC. Transformation Health is an independent publisher. It does not provide medical care, prescribe, or sell medication, and does not give medical advice. Providers and programs mentioned on this site are independent third parties.

How We Make Money

Transformation Health does not accept payment from providers.

Educational Purpose

This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Results vary. Trial results describe study participants and are not a prediction for any individual.

Compounded Medications

Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy, Ozempic, Zepbound, or Mounjaro. They may differ in formulation, purity, and potency.

Trademarks

Wegovy and Ozempic are trademarks of Novo Nordisk A/S. Zepbound and Mounjaro are trademarks of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by these companies.